Your browser doesn't support javascript.
loading
Long-Term Biocompatibility of a Highly Viscously Thiol-Modified Cross-Linked Hyaluronate as a Novel Vitreous Body Substitute.
Hurst, Jose; Rickmann, Annekatrin; Heider, Nele; Hohenadl, Christine; Reither, Charlotte; Schatz, Andreas; Schnichels, Sven; Januschowski, Kai; Spitzer, Martin S.
Affiliation
  • Hurst J; Centre of Ophthalmology, University Eye Hospital Tübingen, Tübingen, Germany.
  • Rickmann A; Eye Clinic Sulzbach, Knappschafts Hospital Sulzbach/Saar, Sulzbach, Germany.
  • Heider N; Centre of Ophthalmology, University Eye Hospital Tübingen, Tübingen, Germany.
  • Hohenadl C; Croma Pharma GmbH, Leobendorf, Austria.
  • Reither C; Croma Pharma GmbH, Leobendorf, Austria.
  • Schatz A; Centre of Ophthalmology, University Eye Hospital Tübingen, Tübingen, Germany.
  • Schnichels S; Centre of Ophthalmology, University Eye Hospital Tübingen, Tübingen, Germany.
  • Januschowski K; Centre of Ophthalmology, University Eye Hospital Tübingen, Tübingen, Germany.
  • Spitzer MS; Mount St. Peter Eye Clinic Trier, Trier, Germany.
Front Pharmacol ; 13: 817353, 2022.
Article in En | MEDLINE | ID: mdl-35308238